Liminatus Pharma LIMN 深 沪
已收盘 02-06 16:00:00 美东时间
1.84
-0.210
-10.24%
华盛通- 最 高2.63
- 今 开2.15
- 成交量 4872.09万股
- 最 低 1.60
- 昨 收 2.05
- 总市值 4979.89万
- 52周最高 33.66
- 市盈率 静 --
- 换手率 180.02%
- 52周最低 0.5399
- 委 比 74.84%
- 总股本 2706.46万
- 历史最高 33.66
- 量 比 0.90
- 振 幅 50.24%
- 历史最低 0.5399
- 每 手 1
- 风险率 5.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Liminatus Pharma Faces Nasdaq Bid Price Compliance Challenge
An update from Liminatus Pharma ( ($LIMN) ) is now available. On January 15, 20...
01-27 06:07
Liminatus Pharma Faces Nasdaq Delisting Risk Over Sub-$1 Share Price
Liminatus Pharma Faces Nasdaq Delisting Risk Over Sub-$1 Share Price Liminatus Pharma Inc. has received a notice from the Nasdaq Listing Qualifications Department indicating that the company is no longer in compliance with the Nasdaq Listing Rule 5450(a)(1), which requires listed securities to maint
01-27 05:31
Liminatus Pharma Faces Nasdaq Non-Compliance Notice
Liminatus Pharma ( ($LIMN) ) just unveiled an announcement. On November 19, 202...
2025-11-26 06:49
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Advanced Biomed (NASDAQ:ADVB) stock rose 29.6% to $0.48 during Monday'...
2025-11-25 01:05
Liminatus Pharma Signs MOU With Capital Trust Group For $30M Equity Financing Via Earn-Out Mechanism To Support Liminatus's R&D Of Advanced Immunotherapy Assets
Liminatus Pharma, Inc. (NASDAQ:LIMN), La Palma, CA, a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it has entered into a Memorandum of Understanding
2025-10-28 01:38
纳斯达克监管收紧背景下的不同DAT策略再审视
纳斯达克针对数字资产公司出台新监管措施，要求发行新股资助加密货币采购需提交股东大会表决。分析DAT策略（Digital Asset Treasury），即上市公司通过融资购买主流代币填充资产负债表，如BTC、ETH、SOL等。本文探讨其发展模式、风险及各类资产的对比。BTC DAT遭遇市场寒潮，而ETH和SOL因其收益结构和潜力受到关注。非主流资产如BNB、Ethena和SUI也在积极探索DAT布局。尽管DAT模式在牛市时能放大收益，但其可持续性依赖市场情绪和监管政策，需警惕mNAV折价及监管风险。
2025-09-09 07:27
Liminatus Pharma Faces Nasdaq Non-Compliance Notice
Liminatus Pharma ( ($LIMN) ) has provided an announcement. On August 22, 2025, ...
2025-08-26 05:50
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers ModivCare (NASDAQ:MODV) stock increased by 69.6% to $0.95 during Frida...
2025-08-22 20:08
Liminatus Pharma Updates on CD47 Inhibitor IBA101
Liminatus Pharma ( ($LIMN) ) has provided an announcement. On August 14, 2025, ...
2025-08-15 04:28
美股医疗公司Liminatus Pharma大涨超5%！拟筹募5亿美元资金全力投资BNB
Liminatus Pharma宣布计划成立子公司「American BNB Strategy」专注于投资BNB。
2025-07-28 12:33
